{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T16:18:48Z","timestamp":1715789928935},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,18]]},"DOI":"10.7759\/cureus.9837","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T15:38:44Z","timestamp":1597765124000},"source":"Crossref","is-referenced-by-count":3,"title":["Paradoxical Stress Fracture in a Patient With Multiple Myeloma and Bisphosphonate Use"],"prefix":"10.7759","author":[{"given":"Edwin","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cabanero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurinder","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24402","article-title":"Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016, 91:719-734. 10.1002\/ajh.24402","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.7901","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"31","author":"Terpos E","year":"2013","unstructured":"Terpos E, Morgan G, Dimopoulos MA, et al.. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol. 2013, 31:2347-2357. 10.1200\/JCO.2012.47.7901","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0215","article-title":"NCCN Task Force Report: bone health in cancer care","volume":"3","author":"Gralow JR","year":"2013","unstructured":"Gralow JR, Biermann JS, Farooki A, et al.. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw. 2013, 3:1-50. 10.6004\/jnccn.2013.0215","journal-title":"J Natl Compr Canc Netw"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"10","author":"Kyle RA","year":"2007","unstructured":"Kyle RA, Yee GC, Somerfield MR, et al.. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007, 10:2464-2472. 10.1200\/JCO.2007.12.1269","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"13","author":"Black DM","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, et al.. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010, 13:1761-1771. 10.1056\/NEJMoa1001086","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek EB","year":"2008","unstructured":"Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury. 2008, 39:224-231. 10.1016\/j.injury.2007.08.036","journal-title":"Injury"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-2194-2","article-title":"Femoral stress fractures associated with long-term bisphosphonate treatment","volume":"470","author":"Ward WG Sr","year":"2012","unstructured":"Ward WG Sr, Carter CJ, Wilson SC, Emory CL. Femoral stress fractures associated with long-term bisphosphonate treatment. Clin Orthop Relat Res. 2012, 470:759-765. 10.1007\/s11999-011-2194-2","journal-title":"Clin Orthop Relat Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0225","article-title":"The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future","volume":"16","author":"Pozzi S","year":"2011","unstructured":"Pozzi S, Raje N. The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. Oncologist. 2011, 16:651-662. 10.1634\/theoncologist.2010-0225","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12239","article-title":"Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review","volume":"92","author":"Alegre A","year":"2014","unstructured":"Alegre A, Gironella M, Bail\u00e9n A, Giraldo P. Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review. Eur J Haematol. 2014, 92:181-188. 10.1111\/ejh.12239","journal-title":"Eur J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.11.005","article-title":"Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates","volume":"67","author":"Grasko JM","year":"2009","unstructured":"Grasko JM, Herrmann RP, Vasikaran SD. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates. J Oral Maxillofac Surg. 2009 Mar, 67:645-9. 10.1016\/j.joms.2008.11.005","journal-title":"J Oral Maxillofac Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1012-0","article-title":"Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies","volume":"21","author":"Napoli N","year":"2010","unstructured":"Napoli N, Novack D, Armamento-Villareal R. Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies. Osteoporos Int. 2010, 21:705-708. 10.1007\/s00198-009-1012-0","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang ST","year":"2012","unstructured":"Chang ST, Tenforde AS, Grimsrud CD, et al.. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012, 51:524-527. 10.1016\/j.bone.2012.05.010","journal-title":"Bone"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11420-008-9077-4","article-title":"Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid","volume":"4","author":"Wernecke G","year":"2008","unstructured":"Wernecke G, Namdari S, DiCarlo EF, Schneider R, Lane J. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSS J. 2008, 4:123-127. 10.1007\/s11420-008-9077-4","journal-title":"HSS J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"6","author":"Puhaindran ME","year":"2011","unstructured":"Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am. 2011, 6:1235-1242. 10.2106\/JBJS.J.01199","journal-title":"J Bone Joint Surg Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.02.009","article-title":"Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures","volume":"50","author":"Abrahamsen B","year":"2012","unstructured":"Abrahamsen B, Einhorn TA. Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures. Bone. 2012, 50:1196-1200. 10.1016\/j.bone.2012.02.009","journal-title":"Bone"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane E","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, et al.. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014, 29:1-23. 10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina CV","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005, 90:1294-1301. 10.1210\/jc.2004-0952","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba T","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000, 15:613-620. 10.1359\/jbmr.2000.15.4.613","journal-title":"J Bone Miner Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12007","article-title":"The role of imaging techniques in the management of multiple myeloma","volume":"159","author":"Zamagni E","year":"2012","unstructured":"Zamagni E, Cavo M. The role of imaging techniques in the management of multiple myeloma. Br J Haematol. 2012, 159:499-513. 10.1111\/bjh.12007","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/24946-paradoxical-stress-fracture-in-a-patient-with-multiple-myeloma-and-bisphosphonate-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:30Z","timestamp":1707506670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/24946-paradoxical-stress-fracture-in-a-patient-with-multiple-myeloma-and-bisphosphonate-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.9837","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}